Background: Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induced antibody level wanes over time. Peak vaccine-induced anti-HBs level is directly related to antibody decay, as well as risk of infection and persistent carriage despite vaccination. We investigated the role of host genetic factors in long-term immunity against HBV infection based on peak anti-HBs level and seroconversion to anti-HBc. Methods: We analyzed 715 SNP across 133 candidate genes in 662 infant vaccinees from The Gambia, assessing peak vaccine-induced anti-HBs level and core antibody (anti-HBc) status, whilst adjusting for covariates. A replication study comprised 43 SNPs in a further 393 individuals. Results: In our in...
ABSTRACT Worldwide about 350 million people are chronic carriers of the hepatitis B virus (HBV). The...
BACKGROUND/AIMS:The seroclearance of hepatitis B virus (HBV) surface antigen (HBsAg) is regarded as ...
Objective: The hepatitis B virus (HBV)-polymerase region overlaps pre-S/S genes with high epitope de...
Background: Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, va...
BACKGROUND: Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, va...
Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induce...
Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines ...
Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines ...
The immune response to hepatitis B vaccination differs greatly among individuals, with 5-10% of heal...
It is well documented that 5-10% hepatitis B adult vaccinees are non- and hypo-responders and probab...
Background. Hepatitis B virus (HBV) is an important cause of chronic viral disease worldwide and can...
The disease burden due to hepatitis B virus (HBV) infection remains significant; 350 million people ...
Genetic predisposition towards antibody nonresponsiveness has been described for many antigens in bo...
BACKGROUND: Impact of hepatitis B virus genetic barrier, defined as the number and type of nucleotid...
IL-1beta gene polymorphisms influence hepatitis B vaccination.Yucesoy B, Sleijffers A, Kashon M, Gar...
ABSTRACT Worldwide about 350 million people are chronic carriers of the hepatitis B virus (HBV). The...
BACKGROUND/AIMS:The seroclearance of hepatitis B virus (HBV) surface antigen (HBsAg) is regarded as ...
Objective: The hepatitis B virus (HBV)-polymerase region overlaps pre-S/S genes with high epitope de...
Background: Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, va...
BACKGROUND: Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, va...
Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induce...
Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines ...
Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines ...
The immune response to hepatitis B vaccination differs greatly among individuals, with 5-10% of heal...
It is well documented that 5-10% hepatitis B adult vaccinees are non- and hypo-responders and probab...
Background. Hepatitis B virus (HBV) is an important cause of chronic viral disease worldwide and can...
The disease burden due to hepatitis B virus (HBV) infection remains significant; 350 million people ...
Genetic predisposition towards antibody nonresponsiveness has been described for many antigens in bo...
BACKGROUND: Impact of hepatitis B virus genetic barrier, defined as the number and type of nucleotid...
IL-1beta gene polymorphisms influence hepatitis B vaccination.Yucesoy B, Sleijffers A, Kashon M, Gar...
ABSTRACT Worldwide about 350 million people are chronic carriers of the hepatitis B virus (HBV). The...
BACKGROUND/AIMS:The seroclearance of hepatitis B virus (HBV) surface antigen (HBsAg) is regarded as ...
Objective: The hepatitis B virus (HBV)-polymerase region overlaps pre-S/S genes with high epitope de...